NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Subscribe
A ground-breaking discovery into the mechanisms driving Rett syndrome was unveiled during the 2023 World Congress of Neurology.
Research by Prof Huda Zoghbi, Professor of Molecular and Human Genetics, Baylor College of Medicine, Texas, US, shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood disorder that primarily affects females and is diagnosed in around one-in-10,000 girls born each year.
Rett syndrome is a delayed-onset childhood disorder that causes a broad range of severe neurological disabilities, including loss of the ability to speak and socialise, and the development of tremors, ataxia, seizures, autonomic dysfunction, and stereotypic hand-wringing movements.
Prof Zoghbi’s ground-breaking research not only enhances understanding of Rett syndrome, but also reveals its connection to a spectrum of neuropsychiatric phenotypes, from autism to bipolar disorders.
Using genetically-engineered mice, Prof Zoghbi and her team learned that the brain is acutely sensitive to MeCP2 levels. Both decreases and increases in the amount of MeCP2 protein can lead to neurological problems that are also observed in humans. Prof Zoghbi found that normalising MeCP2 levels in a mouse model can reverse disease-like features of the human MECP2 duplication syndrome, a disorder that is usually found in boys and results from excess MeCP2 protein.
Her research also pinpointed the specific neurons and circuit abnormalities that mediate the various symptoms of Rett syndrome. Using either deep brain stimulation or intense pre-symptomatic training of a Rett syndrome mouse model, her team showed that many symptoms can be normalised.
“The fact that either deep brain stimulation or intense pre-symptomatic training can normalise circuit function and behaviour is quite exciting as it tells us that such interventions have the potential to help patients,” said Prof Zoghbi.
This knowledge will create the foundation for researchers to explore deep brain stimulation as an option to treat several Rett syndrome phenotypes, offering potential relief for affected individuals. Moreover, this research has far-reaching implications, not only for Rett syndrome, but for a broader spectrum of neuropsychiatric disorders.
Positive results from the TROPION-Breast01 phase 3 trial showed that a specifically engineered TROP2...
Shared decision-making is more than being attentive to patients’ needs or concerns – it also represents...
The Judge's report proposes that a Tribunal be established under legislation to hear and determine claims...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.